You are here
About the Programme
This global education programme will contain 13 courses covering 4 areas: basal insulin analogues, new fixed ratio basal-bolus insulin therapy, basal GLP-1 RA combination therapy and new ultra-fast-acting insulin analogues. The editorial board will act as independent expert reviewers, and will curate all content.
The programme provides diabetologists, endocrinologists, and primary care physicians with free access to information on diabetes management, including recently published articles, congress highlights, and interactive educational courses related to the use of basal insulin analogues alone, in combination with other insulins, and alongside a glucagon-like peptide 1 (GLP-1) receptor agonist (RA).
The courses provide patient case discussions, clinical article reviews, and infographics, and an overview of the latest clinical data on novel insulin analogues and patient counselling approaches.
The editorial board will act as independent expert reviewers, and will curate all content.
A single registration gives you access to all courses
The Insulin Educational Programme is free and available to all site visitors, you only need to register once and you will have access to all content and courses.
Each course is divided in different content modules that some of these modules are webcasts, case studies, articles, roundtable discussions or animated tables. You can start a course and complete it's modules in any order. After each module you will have a short quiz and will be able to proceed to the next content.
13 courses organized in 4 content areas:
Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk